Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Investigating Physiological Functions of Vitamin A Transporters Using HPLC-Based Vitamin A Profiling
Published on: December 27, 2024
Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date
Vladimir Lerner1, Peter J A McCaffery2, Michael S Ritsner3,4
1Faculty of Health Sciences, Be'er Sheva Mental Health Center, Ben-Gurion University of the Negev, Beersheba, Israel.
Targeting retinoid receptors may offer a novel treatment for schizophrenia and schizoaffective disorder. Retinoic acid plays a role in brain function and psychotic states, suggesting potential therapeutic avenues.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Retinoic acid is crucial for normal brain function.
- Dysregulation of retinoids is implicated in schizophrenia.
- Retinoid receptors represent potential therapeutic targets for psychiatric disorders.
Purpose of the Study:
- To review the rationale for targeting retinoid receptors in schizophrenia and schizoaffective disorder.
- To discuss the role of retinoic acid in normal brain function and psychotic states.
- To present progress and findings from clinical trials investigating retinoid-based treatments.
Main Methods:
- Literature review of retinoic acid's function in the brain.
- Examination of evidence for retinoid dysregulation in schizophrenia.
- Discussion of clinical trial data for bexarotene as an add-on therapy.
Main Results:
- Retinoic acid has established roles in brain physiology.
- Evidence suggests altered retinoid signaling in schizophrenia.
- Preliminary clinical trials with bexarotene show potential as an add-on treatment.
Conclusions:
- Targeting retinoid receptors presents a novel therapeutic strategy for schizophrenia and schizoaffective disorder.
- Further research and clinical studies are necessary to validate this approach.
- Understanding retinoid pathways could unlock new treatment paradigms for psychosis.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...

